raloxifene hydrochloride has been researched along with Diabetic Nephropathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araki, S; Chin, M; Guo, B; Haneda, M; Isono, M; Isshiki, K; Kashiwagi, A; Koya, D; Sato, H; Sugimoto, T | 1 |
Babayan, R; Dixon, A; Maric, C; Singh, S; Wells, CC | 1 |
Chabin, M; Gautier, JF; Gourdy, P; Guerci, B; Hadjadj, S; Mauco, G; Ragot, S; Roudaut, N; Zaoui, P | 1 |
1 trial(s) available for raloxifene hydrochloride and Diabetic Nephropathies
Article | Year |
---|---|
Effect of raloxifene -- a selective oestrogen receptor modulator -- on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial.
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Middle Aged; Pilot Projects; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2007 |
2 other study(ies) available for raloxifene hydrochloride and Diabetic Nephropathies
Article | Year |
---|---|
Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Estradiol; Female; Fibronectins; Glomerular Mesangium; Kidney; Mice; Mice, Mutant Strains; Ovariectomy; Raloxifene Hydrochloride; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators | 2005 |
Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy.
Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Female; Kidney; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators | 2007 |